Technical420 Site Search

During the last year, leading Canadian broker-dealers have been downgrading Canadian Licensed Producers’ (LPs) rating on average. The banks have also been lowering price targets for Canadian LPs and we consider this to be a bearish indicator.  Although we continue to hope to see a change in trend with rating…

Cronos Group Inc. (TSX: CRON) (Nasdaq: CRON) has taken the market on a roller coaster ride this week and we believe our readers should be aware of the volatile price swings.  The Canadian Licensed Producer (LP) started the week on a positive note and the shares surged more than 25%…

On Friday, Cronos Group Inc. (TSX: CRON) (Nasdaq: CRON) released second quarter financial results and reported several important developments. From higher cannabis sales to the appointment of a new CFO, we believe that Cronos is in the early innings of a major growth cycle. We believe the Canadian cannabis company…

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), announces the launch of SOURZ by Spinach™, an exciting new line of cannabis gummies with bold and unique dual flavor combinations featuring proprietary flavor masking technology. SOURZ by Spinach™ gummies were developed by Cronos Group’s experienced team of professional chefs, food scientists, consumer…

Last year, Israel overtook Germany as the largest importer of medical cannabis, and this is a market that we are bullish on. One of the reasons we are excited about the Israeli cannabis market is related to the economics that are associated with the cultivation process. In Israel, the cost…

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) and PharmaCann Inc., one of the largest vertically integrated cannabis companies in the United States , today announced that they have entered into an agreement under which a wholly owned subsidiary of Cronos Group has purchased an option to acquire an approximately 10.5%…

After leading Canadian Licensed Producers (LPs) announced quarterly financial results that came in lower than what many broker-dealers expected, several firms have issued new ratings and/or price targets on several LPs. Several of the price target decreases are substantial and we find the changes to be worth highlighting. We attribute…

Earlier this month, broker-dealers provided mixed signals on Cronos Group Inc. (Nasdaq: CRON) (TSX: CRON) following a lackluster first quarter earnings report. While one broker-dealer raised its price target on the Canadian Licensed Producer (LP), another firm lowered its price target and we find the disconnect to be a sign…

Last week, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) released first quarter financial results and the numbers came in lower than we expected During the quarter, Cronos reported an adjusted EBITDA loss of $37.1 million on $12.6 million of revenue. When compared to the same quarter last year, the size of…

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today released a Marketing Code designed to responsibly move the emerging cannabis industry forward. Cronos Group believes that those below the legal age of consumption should not be targeted in an adult-use cannabis market. Cronos Group recognizes there…